Awaiting FDA clinical hold letter on MAGNITUDE and MAGNITUDE-2 clinical trials of nex-zPresenting longer-term Phase 1 ...
Biopharmaceuticals: Redefining the Future of Modern MedicineThe Global Bio Pharmaceuticals Market is valued at USD 421.58 ...
Thus, this new site-specific and cassette mutagenesis method is highly efficient, fast and versatile, likely resulting in its wide use for typical ...
Technology opens the door to more accurate preclinical testing, which could enable the development of safer and more effective therapies.
Jarome and his team found that aging disrupts K63 polyubiquitination in two distinct areas of the brain. In the hippocampus, ...
CHINO HILLS, CALIFORNIA / ACCESS Newswire / November 6, 2025 / SOHM, Inc. , a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, a leader in Gene Editing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results